Compare ZTEK & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZTEK | BDSX |
|---|---|---|
| Founded | 2008 | 2005 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Precision Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 78.2M | 88.3M |
| IPO Year | N/A | N/A |
| Metric | ZTEK | BDSX |
|---|---|---|
| Price | $0.67 | $12.09 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $32.50 |
| AVG Volume (30 Days) | 70.2K | ★ 262.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $22.01 |
| Revenue Next Year | N/A | $26.81 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.60 | $3.44 |
| 52 Week High | $1.84 | $20.40 |
| Indicator | ZTEK | BDSX |
|---|---|---|
| Relative Strength Index (RSI) | 38.88 | 67.15 |
| Support Level | $0.62 | $9.83 |
| Resistance Level | $0.69 | $13.63 |
| Average True Range (ATR) | 0.07 | 1.37 |
| MACD | -0.01 | 0.08 |
| Stochastic Oscillator | 17.10 | 79.75 |
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.